At a glance
ClinicalIndex Comparison RecordN/ACompleted· 52 enrolled
Drug / intervention
Tecnis Synergy IOLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating the New Synergy IOL - First 7 Months Data From Two US Centers
In Brief
An observational study evaluating Tecnis Synergy IOL for Presbyopia and Pseudophakia. Completed, enrolled 52 participants across 2 sites.
Detailed Summary
This is a single visit study to evaluate the visual outcomes and patient satisfaction of patients who were bilaterally implanted with the Tecnis Synergy IOL between June 1 and December 31, 2021 in 2 centers in USA
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia, Pseudophakia
CountriesUnited States
CollaboratorsScience in Vision
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartMar 2022
First PostedJun 2022
Primary CompletionNov 2022
TodayJul 2026
First PostedJun 14, 2022
Enrollment StartMar 14, 2022
Primary CompletionNov 22, 2022
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.0 years ago
Interventions
Tecnis Synergy IOLdevice
Intraocular lens replaces the natural lens removed during cataract surgery in both eyes.